Klotho Skin Announces Partnership with Leonhardt Ventures

Innovative longevity-based skincare now available through leading platform for purpose-driven brands

Los Angeles, CA - September 18, 2025 - Klotho Skin, a pioneer in genetics-based skincare, is proud to announce that its products are now available on Leonhardt Ventures, a platform dedicated to supporting innovative and mission-driven companies.
Known for its groundbreaking work with the Klotho gene, a key regulator of aging, Klotho Skin offers the first skincare line designed to work at the genetic level, promoting skin vitality, longevity, and overall health.
Dr. Gail Humble, CEO of Klotho Skin, shared her excitement about this new milestone:
"Klotho Skin is thrilled to have our products listed on Leonhardt Ventures. Partnering with a platform that champions innovative, purpose-driven brands is an exciting milestone for us, and it allows us to introduce more people to our science-led approach to skin health and longevity. We're grateful for the opportunity and look forward to serving the leonhardtventures.com community with high-performance formulas that elevate everyday routines and deliver real results."
The addition of Klotho Skin to Leonhardt Ventures strengthens the platform's commitment to offering consumers access to products that go beyond the ordinary, combining science, innovation, and purpose to improve quality of life.
For more information or to shop the collection, visit the Klotho Shop or Leonhardt Ventures.

909 Hyde Street, Suite 330 SF,
CA 94109

Founded by Dr. Gail Humble, Klotho Skin is the first skincare line powered by Klotho protein, a breakthrough in regenerative medicine. With over two decades of research, the brand's mission is to transform skin health at the genetic level, delivering powerful, science-led formulas that promote youthful, resilient, and radiant skin.

This release was published on openPR.